Delivery Order SPE2DB22D3016-SPE2DB24FAZS0

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,518.48 Delivery Order is for the supply of 4564883947 - Neulasta OnPro 6 mg/0.6 mL kits. The contract has a firm fixed price and an ultimate completion date of June 13, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,729.49, is for the supply of Neulasta OnPro 6 mg/0.6 ml kits to support federal healthcare programs, particularly military and veterans' healthcare systems. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,240.95, is for the supply of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Neulasta OnPro 6 mg/0.6 ml kits. The order, valued at $6,176.80, has a completion date of February 8, 2024. Amerisourcebergen Drug Corp provides pharmaceuticals, medical supplies, and related distribution services to support military treatment programs and facilities under an indefinite delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply Neulasta OnPro 6 mg/0.6 ml kits. The potential value of this order is $6,777.72, with a completion date of January 22, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has an established history of providing pharmaceutical products and medical supplies to support DLA Troop Support...
This federal contract award is for the delivery of the pharmaceutical product Neulasta 6 mg/0.6 mL syringe to the Defense Logistics Agency (DLA). The contract, valued at $2,038.95, was awarded to the prime contractor Amerisourcebergen Drug Corp, which is the corporate office division of the larger Amerisourcebergen Corporation. The contract is a delivery order under an existing Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,035.48 firm fixed price delivery order is for the supply of NEULASTA 6 MG/0.6 ML SYRINGE 0.6ML, a specialty medication, with a performance period through April 2025. The contract is not designated with a set-aside and represents open competition. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of a variety of pharmaceutical products and medical supplies to support the Medical Supply Chain of the Defense Logistics Agency (DLA). The contract, which has a ceiling value of $5,724.36, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide pharmaceutical products and medical supplies to military treatment programs and facilities. The contract has a ceiling value of $8,575.36 and a performance period through March 20, 2024. This award is associated with a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, which is a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $16,604.80 and an ultimate completion date of July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAZS0
    Delivery Order

This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Neulasta Onpro 6 mg/0.6 ml kits to the Defense Logistics Agency (DLA). The contract has a ceiling value of $36,282.12 and an ultimate completion date of July 1, 2024. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 9/27/24, 9:31 AM